港股午評:快速拉昇!恒指大升1.4%, 科技股、大金融股齊升
分析人士稱市場可能預期會有刺激政策出台,港A市場上午盤異動拉昇,截止午盤,恒指、國指分別上升1.4%及1.58%,恒生科技指數升1.72%。盤面上,作為市場風向標的大型科技股集體拉昇,京東、美團、阿里巴巴、快手均轉升超2%,騰訊、百度升超1%;大金融股(銀行、保險、券商)、中字頭股齊升;生物醫藥股大幅拉昇,龍頭股藥明康德大升近10%,半導體股、航空股、汽車股、鋰電池股、內房股普遍表現強勢,餐飲股、體育用品股等消費概念股走高。另一方面,昨日強勢的蘋果概念股集體回調,丘鈦科技跌超5%,豬肉概念股、光伏股、稀土概念股普遍表現低迷。(格隆匯)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.